About 100 reports

‘Antibody-Mediated Rejection (AMR) – Market Insights, Epidemiology, and Market Forecast—2030’ report deliver an in-depth understanding of the AMR, historical and forecasted epidemiology as well as the market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The AMR market report provides current...

  • Epidemiology
  • Monoclonal Antibody
  • Transplantation
  • United States
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Drug Approval

“Etanercept - Emerging Insight and Market Forecast - 2030” the report provides comprehensive insights about an investigational product for Cutaneous Lupus Erythematosus in 7 Major Markets. A detailed picture of the Etanercept in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Monoclonal Antibody
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

AzurRx BioPharma Inc (AzurRx BioPharma) is a development stage biopharmaceutical company that research and develops non-systemic biologics for the treatment of patients with gastrointestinal disorders.

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • United States
  • France
  • New York
  • Prescription Drug Sales
  • Food Consumption

Report Scope The current report provides detailed exposure of media, sera and reagents used in cell culture.This report highlights the current and future market potential of culture media, sera and reagents used in cell culture along with a detailed analysis of the competitive environment, regulatory scenario, and technological...

  • Cell Therapy
  • World
  • Europe
  • North America
  • APAC
  • China
  • Japan
  • Middle East
  • United States
  • Mexico
  • United Kingdom
  • Canada
  • France
  • Germany
  • India

KBI Biopharma Inc (KBI) a subsidiary of JSR Corp is a biopharmaceutical contract development and manufacturing organization that develops novel discoveries into life changing biological products.

  • Biopharmaceutical
  • Pharmaceutical
  • Healthcare
  • Belgium
  • Europe

Stemedica San Diego County California Cell Therapy Biopharmaceutical Regenerative Medicine Pharmaceutical

  • Cell Therapy
  • Europe
  • United Kingdom
  • France
  • Chronic Disease Prevalence
  • Cause-Specific Mortality Rate

‘Gene and Cell Therapies targeting CNS Disorders – Market Insights and Market Forecast – 2026’ report delivers an in-depth understanding of the market trends of Gene and Cell Therapies targeting CNS Disorders in in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Gene and Cell Therapies targeting...

  • Cell Therapy
  • Mental Health
  • World
  • Spain
  • France
  • Germany
  • United States
  • Italy
  • United Kingdom
  • Health Expenditure

‘B-cell Non-Hodgkin’s Lymphoma—Market Insights, Epidemiology, and Market Forecast—2028’ report deliver an in-depth understanding of the disease, historical and forecasted epidemiology as well as the market trends of B-cell NHL in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan. Geography...

  • Immunotherapy
  • Lymphoma
  • Spain
  • Germany
  • France
  • Japan
  • United States
  • Italy
  • United Kingdom
  • Stem Cell Transplantation

World Biopharmaceutical

  • Therapy
  • Cell Therapy
  • Oncology
  • Oncology
  • Pharmaceutical
  • Biopharmaceutical
  • World
  • Belgium
  • Pharmaceutical Registrations
  • Drug Approval

Dec ##: KBI Biopharma and Selexis form joint Scientific Advisory Board

  • Cell Therapy
  • Pharmaceutical
  • Healthcare
  • Switzerland
  • Pharmaceutical Exports
  • Energy Supply

‘Adeno-Associated Virus (AAV) Vector Based Gene Therapy - Market Insights, Epidemiology and Market Forecast—2030’ report delivers an in-depth understanding of the AAV Vector Based Gene Therapy, historical and forecasted epidemiology as well as the AAV Vector Based Gene Therapy market trends in the United States, EU5 (Germany, France, Italy,...

  • Gene Therapy
  • United States
  • Germany
  • Spain
  • France
  • Japan
  • Italy
  • United Kingdom
  • Medical Technology Density
  • Hospital Admission

Greenovation Biotech GmbH (Greenovation) is a biopharmaceutical company that develops next generation therapeutics for orphan diseases.

  • Neurological Disorder
  • Gene Therapy
  • World
  • Belgium
  • Pharmaceutical Exports
  • Biologics Production

Benitec Biopharma Ltd

  • Gene Therapy
  • Healthcare
  • Pharmaceutical
  • California
  • Baden-Württemberg
  • Prescription Drug Sales
  • Health Provider Density

Europe Pharmaceutical Immunotherapy Clinical Trial Biopharmaceutical Lymphoma

  • Pharmaceutical
  • Immunotherapy
  • Healthcare
  • California
  • Netherlands
  • World
  • Israel
  • Manufacturing Output
  • Practising Physicians

Evaluation of Therapeutic Segments Including Monoclonal Antibodies, Insulin, Fusion Proteins, Interferons and Gene Therapies; Prediction of Leading National Markets (US, Japan, EU5 and BRIC); Investigation of Top Products Including Humira, Remicade, Lantus and Enbrel; and Assessment of R&D Including Sirukumab and NurOwn Report...

  • Biopharmaceutical
  • Pharmaceutical
  • Regenerative Medicine
  • Gene Therapy
  • Monoclonal Antibody
  • Japan
  • United States
  • BRIC
  • Spain
  • China
  • France
  • Germany
  • Russia
  • India
  • Italy
  • Brazil
  • United Kingdom

Array BioPharma Inc

  • Pharmaceutical
  • Biopharmaceutical
  • Healthcare
  • Monoclonal Antibody
  • Clinical Trial
  • Bavaria
  • Sweden
  • Greenhouse Gas Emissions
  • Prescription Drug Sales

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Clinical Research
  • Pancreatic Cancer
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
  • Direct Sales
  • Manufacturing Orders

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Hospital
  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Pancreatic Cancer
  • Germany
  • Direct Sales
  • Medical Devices Sales

Hemispherx Biopharma, Inc. said it is expanding its partnership with myTomorrows to supply Ampligen for pancreatic cancer patients in Canada under a Special Access Program (SAP).

  • Orthopedics
  • Clinical Trial
  • Gene Therapy
  • Pancreatic Cancer
  • Germany
  • Direct Sales
  • Drug Approval

Cyxone AB, a biopharmaceutical company, has agreed to acquire the entire family of patents protecting its main candidate T##K, from the Medical University of Vienna (MedUni Vienna), a medical research institution.

  • Immunotherapy
  • Cancer
  • Pharmaceutical
  • Neurological Disorder
  • Healthcare
  • Blood Disease
  • Cardiovascular Disease
  • Brain Cancer
  • Compression Therapy
  • Austria
  • Cancer Mortality
  • Cause-Specific Mortality Rate

Can new biologics breathe fresh competition into the targeted asthma treatment landscape? The severe asthma treatment landscape is evolving. Near-term debates will focus on how best to use currently approved treatments, including Xolair, Nucala and Cinqair/Cinqaero, and which treatments offer the best for patients. Visible on the horizon...

  • Asthma
  • Respiratory Treatment
  • Monoclonal Antibody
  • Germany
  • Europe
  • United States
  • Occitanie

APEIRON Biologics EUSA Pharma ViraTherapeutics Austria European Union Pharmaceutical Biopharmaceutical

  • Pharmaceutical
  • Biopharmaceutical
  • Healthcare
  • Austria
  • Europe
  • Stem Cell Transplantation
  • Manufacturing Output

The report presents a detailed analysis of the Papillomavirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Papillomavirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market...

  • Diagnostics
  • Public Health
  • Monoclonal Antibody
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

The report presents a detailed analysis of the Pneumonia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Pneumonia definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:

  • Infectious Disease
  • Diagnostics
  • Public Health
  • Monoclonal Antibody
  • Europe
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom

ADC Therapeutics Genmab MedImmune Cancer Research Technology AstraZeneca BerGenBio Chiome Bioscience LivTech Celtic Therapeutics BioAtla Adlib Five Prime Therapeutics Redmile Group Cancer Research Campaign Technology Limited Sprout Pharmaceuticals Spirogen, Ltd Arzerra Kolltan Pharmaceuticals Therapeutics SA Lonza Galaxy Biotech Ferring International Center SA Genentech Global Regulatory Affairs Bristol-Myers Squibb Zai Lab Switzerland United Kingdom Stem Cell Transplantation Foreign Direct Investment Drug Approval Biopharmaceutical Therapy Pharmaceutical Healthcare Private Placement

  • Biopharmaceutical
  • Therapy
  • Pharmaceutical
  • Healthcare
  • Private Placement
  • Switzerland
  • United Kingdom
  • Stem Cell Transplantation
  • Foreign Direct Investment

MeiraGTx Limited, a company engaged in the development of novel gene therapy treatments, has acquired Kadmon Gene Therapy Holdings Limited, a company focused on gene therapy treatments, from Kadmon Corporation, LLC, a biopharmaceutical company.

  • Gene Therapy
  • Pharmaceutical
  • Clinical Trial
  • Healthcare
  • United Kingdom
  • England
  • Caddo Parish
  • Germany
  • Land Berlin
  • Working Age Population
  • Number Of R&D Personnel

Alerpharma wholly owns the Spanish-based allergy immunotherapy company Instituto de Immunologia y Alergia, S.A.U. (Inmunal), a spin-out from a biopharmaceutical company, Zeltia S.A.Alerpharma recorded unaudited turnover and pre-tax profits of approximately EUR##.## million (USD##.## million) and EUR##.## (USD##.## million) respectively in the financial year ended December ##, and its unaudited net assets as at December ## were approximately EUR##.## million (USD##.## million).

  • Allergy Immunotherapy
  • Pharmaceutical
  • Healthcare
  • United States
  • Germany
  • Europe
  • Spain
  • United Kingdom
  • Drug Approval

Valneva France Andorra Biopharmaceutical Monoclonal Antibody Financial Services

  • Vaccine
  • Cell Therapy
  • France
  • United States
  • World
  • Medical Technology Density
  • Dates Price

Cellectis Andorra United States France New York Biopharmaceutical Genomics Financial Services

  • Cell Therapy
  • Financial Services
  • France
  • United States
  • Dates Price

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting,...

  • Oncology
  • Laboratory Equipment
  • Monoclonal Antibody
  • Cancer Diagnostics
  • Europe
  • World
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom